Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Indogulf Cropsciences Limited Call Transcript 2025

Nov 10, 2025

59284_rns_2025-11-10_43ec5eb9-8716-4b0b-b583-bf3c3d063dda.pdf

Call Transcript

Open in viewer

Opens in your device viewer

November 10, 2025

To, To, Listing Operation Department Listing Compliance Department BSE Limited National Stock Exchange of India Limited 20[th] Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra Kurla Complex, Dalal Street, Mumbai - 400001 Bandra (East), Mumbai– 400051

Scrip Code: 544432 NSE Symbol: IGCL

Subject: Earnings Call for Q2 FY 2025-26

Dear Sir/ Ma’am,

We wish to inform you that pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the Company will hold its Q2FY26 Earnings Conference Call on November 13, 2025 at 4.00 P.M. IST.

The Management of the Company will host the call to discuss the Company's financial performance, the details of which is enclosed herewith.

This is for your information and appropriate dissemination.

Thanking you,

Yours faithfully, For Indogulf Cropsciences Limited

SAKSHI Digitally signed by SAKSHI JAIN JAIN Date: 2025.11.10 14:34:15 +05'30'

Sakshi Jain

(Company Secretary and Compliance officer) M. No: A67325

Adress: 501, Gopal Heights, Netaji Subhash Place, Delhi – 110034 (India)

==> picture [564 x 197] intentionally omitted <==

You are cordially invited to the Q2 FY26 Earnings Conference Call of Indogulf Cropsciences Limited Scheduled on Thursday, 13[th] November 2025 at 4:00 PM IST

The management will be represented by: Mr. Sanjay Aggarwal Managing Director Mr. Manoj Gupta Chief Financial Officer

Pre-register to avoid the waiting queue, join with Diamond Pass: Registration Link

Conference Dial-In Number

Universal Access

+91 22 6280 1488 +91 22 7115 8869

Hong Kong : 800 964 448 Singapore : 800 101 2045 International Toll Free USA : 1 866 746 2133 UK : 0 808 101 1573

For further information, please contact:

Investor Relations Team –

[email protected]